Bernardo Frider

Summary

Affiliation: Maimonides University
Location: Buenos Aires, Argentina
Summary:
Current Professor Internal Medicine Maimonides University Buenos Aires Argentina 1994 to date
Head Department of Medicine Argerich Hospital. Gov. Buenos Aires. CABA. Argentina 1996 to date.
Clinical Research Experience 1995 Principal Investigator: ?Open randomized, multicenter trial to assess the efficacy of two doses of Roferon A in patients with chronic hepatitis C.? Hoffmann La Roche Ltd. Cosme Argerich General Hospital.
1998 Principal Investigator: ?Response to 12-month treatment with interferon -2 b plus ribavirine in patients with chronic hepatitis c relapser or non responder to a previous IFN treatment? published in Hepatology, 30,4 pt 2, 286a, 1999 Frider B, Findor J, P?rez V, et al. Schering Plough.
2006- Coinvestigator. -Ascitis- protocol .Sanofi-Aventis. 2006-2009.
2006. coinvestigator. Ocurrencia de la ascitis . sanofi aventis. 2006-2009
2007- Principal investigator: Protocol CLDT600 A2406 -Novartis (2007-2009)
2007- Principal investigator: Protocol REALM AI 463-080 ?BMS (2007 ? in course)
2009- Principal Investigator. Protocols CA 182 033, CA 182 034, CA 182 037 BMS (in curse)
2008 - Director of Grant Analysis of the relationship between non-alcoholic fat liver disease, cardiovascular risk and autonomic imbalance an observational pilot study carried out in a cross to general acute care hospital in the Autonomous City of Buenos Aires Ministry of Health Nation, National Health Research grant "Carrillo-O?ativia"

Educational activities:
2008 to 2009. Director. Biannual Course on Hepatology . Argentina Association for the Study of Liver Diseases.
.
2004, 2005, 2006, 2007, 2008, 2009, 2010, 2011. Director. Interuniversitary Course ?Ambulatory Medicine.? Maim?nides University and Osde Foundation . Buenos Aires. Argentina

From 2004 to present, In Charge of the Undergraduate Program in Medical Education. Associate Lecturer at the Faculty of Medicine, University of Buenos Aires, Cosme Argerich Hospital Unit.

2005-2011 Professor of Medicine I, Faculty of Medicine of the Maimonides University, Buenos Aires.

2004 Professor Medicine II, Faculty of Medicine, Maimonides University. Buenos Aires.

2004 Consultant in Gastroenterology, Faculty of Medicine, Maimonides University, Buenos Aires.

2002 - 2003 Associate Professor of Medicine and Gastroenterology, Maimonides University, Buenos Aires.Argentina.

2001 Associate Professor of Medicine II, University Maimonides.Argentina.

2003-2004 & 2006-2007 Member of the Committee on Continuing Medical Education of the Argentina Association for the Study of Liver Diseases.

Director ?Course Diagnosis and Treatment in Internal Medicine, Faculty of Medicine, Maimonides University & Teaching and Research Committee of the General Hospital Cosme Argerich, Buenos Aires. 2002, 2003.2004, 2005 and 2006.

2001 to date: Member of the Jury of the Specialist Course in Pediatric Hepatology, Faculty of Medicine University of Buenos Aires.Argentine.

Investments in 240 opportunities as Rapporteur, Coordinator, President,Moderator or Panelist at conferences and national and international meetings and as a lecturer of courses at various national universities. Some Remarkable in the last five years.

Rapporteur : State of The Art Lecture: Natural History and Course of the Disease. WHO Infromal Working Group on Echinococcosis. Updating the WHO-IWGE Guidelines Meeting. Besancon, France Sept 28, 2007

Rapporteur and Coordinator: Reports of Common Aspects on Alveolar and Cystic Echinococcosis. WHO Informal Working Group on Echinococcosis. Updating the WHO-IWGE Guidelines Meeting.Besancon France Sept 29, 2007

WHO Informal Working Group on Echinococcosis. Updating the WHO-IWGE Guidelines Meeting.Besancon France Sept 29, 2007



Publications: more than 135 publications (such as abstracts, chapters in books, oral presentations at conferences and full articles, Participation in book chapters:
Selected:
Ultrasonograf?a contribution to Concimiento of hydatidosis. Situation of hydatidosis-echinoccosis in Argentina (Denegri, Elissondo Dopchiz, Edits) Editorial Mart?n. 2002. Argentina

Michans Surgery, book. Edit.: Pedro Ferraina and Alejandro Oria. Cholestasis: in Biliary Tract Diseases. Editorial. El Ateneo1997. Argentina

Participation in Medical Associations:
Argentina Medical Association (AMA) Full Member since 1969.
Argentina Society of Gastroenterology (SAGE) Full Member since 1969, Treasurer 1989-1990
Agentine College of Gastroenterologists. Member since 1979.
Argentine Association for the Study of Liver Diseases (AAEEH) member.
President AAEEH / 1994-95.
President of the Argentine Hepatology Congress XIII 2005.
Member of the Latin American Society of Hepatology since 1982.
Corresponding Member of the European Association for the Study of Liver Diseases (EASL) since 2000.
Full member of the International Association of Hydatid Disease since 1985.
Member of Argentina Society of Ultrasound in Medicine and Biology (SAUMB) since 1980.
President SAUMB / 1989-90.
President of the Argentine Congress of Ultrasound in 1989.
Member of Scientific Committee of the Latin American Federation of Ultrasound 1984-91
American Institute of Ultrasound in Medicine, Corresponding Member 1981-86.
Senior Member, American Institute of Ultrasound in Medicine, 1986.

Hospital Activities

1981 -1993 Head of Medical Clinic "A" Unit.. Cosme Argerich Hospital, Buenos Aires

October 1991 - to date, in charge of Hepatology. Hospital Cosme Argerich, Buenos Aires

October 1993 to 2006 Head-Division of Medical Clinic Hospital Cosme Argerich, Buenos Aires.

December 2006 ? Head, Department of Medicine. Hospital Argerich to date.

Publications:
1: Frider B, Bruno A, Zylberman M, Or?a A, Amante M. Autoimmune cholangitis associated to IgG4 related sclerosing disease. Acta Gastroenterol Latinoam. 2011 Mar;41(1):55-9. PubMed PMID: .

2: Frider B, Larrieu E. Treatment of liver hydatidosis: how to treat an asymptomatic carrier? World J Gastroenterol. 2010 Sep 7;16(33):4123-9. PubMed PMID: ; PubMed Central PMCID: PMC2932914.

3: Cuestas ML, Rivero CW, Minassian ML, Castillo AI, Gentile EA, Trinks J, Le?n L, Daleoso G, Frider B, Lezama C, Galoppo M, Giacove G, Mathet VL, Oubi?a JR.
Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina. Antiviral Res. 2010 Jul;87(1):74-7. Epub 2010 Apr 18. PubMed PMID: .

4: Solari J, Galdame O, Rezzonico L, Frider B, Villamil A, Casciato P, Reig M, Bandi JC, Alessio A, Gadano A. [Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study].
Acta Gastroenterol Latinoam. 2009 Dec;39(4):254-60. Spanish. PubMed PMID: .

5: Fassio E, Schroder T; Asociaci?n Argentina para el Estudio de las Enfermedades del H?gado. [Statement of the Argentinian Concensus on Hepatitis C 2007]. Acta
Gastroenterol Latinoam. 2008 Mar;38(1):56-74. Spanish. PubMed PMID: .

6: Paissan A, Wachs A, Arias M, Abelda?o A, Frider B. [Obstructive jaundice associated Burkitts lymphoma mimicking pancreatic carcinoma]. Acta Gastroenterol
Latinoam. 2007 Dec;37(4):246-9. Spanish. PubMed PMID: .

7: Frider B, Alessio A, Pozzati M, Cuestas ML, Mathet VL, Oubi?a JR. Successful interferon treatment in a patient chronically infected with hepatitis B virus carrying unusual S- (and P-) mutants in the presence of anti-HBs antibodies. Liver Int. 2007 Jun;27(5):727-30. PubMed PMID: .

8: Manero E, Frider B, Landeira G. [Treatment of viral hepatitis in HIV-HBV-HCV co-infected patients]. Acta Gastroenterol Latinoam. 2006 Jun;36 Suppl 1:S59-60; discussion S74-82. Spanish. PubMed PMID: .

9: Daruich J, Fainboim H, Frider B. [Primer treatment of acute and chronic hepatitis C]. Acta Gastroenterol Latinoam. 2006 Jun;36 Suppl 1:S52-6; discussion
S74-82. Spanish. PubMed PMID: .


10: Cuestas ML, Mathet VL, Ruiz V, Minassian ML, Rivero C, Sala A, Corach D, Alessio A, Pozzati M, Frider B, Oubi?a JR. Unusual naturally occurring humoral
and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies. J Clin Microbiol. 2006
Jun;44(6):2191-8. PubMed PMID: ; PubMed Central PMCID: PMC1489447.

11: Frider B, Buonsante ME, Tiscornia J, Alessio A, Pellerano G. [Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable
viremia under treatment with peg-interferon plus ribavirin]. Acta Gastroenterol Latinoam. 2006 Mar;36(1):38-41. Spanish. PubMed PMID: .

12: Bessone F, Fern?ndez N, Frider B. [Treatment of hepatitis C in patients with extrahepatic diseases]. Acta Gastroenterol Latinoam. 2005 Jun;35 Suppl 1:S53-5.
Spanish. PubMed PMID: .

13: Frider B, Silva M, Viola L. [Renal failure, hemodialysis and renal transplant]. Acta Gastroenterol Latinoam. 2005 Jun;35 Suppl 1:S13-4. Spanish. PubMed PMID: .

14: Frider B, Rodriguez JA, Porras LC, Amante M. Nonparasitic simple liver cyst: always a benign entity? Unusual presentation of a cystadenoma. Dig Dis Sci. 2005
Feb;50(2):317-9. PubMed PMID: .

15: Frider B, Bruno A, Selser J, Vanesa R, Pascual P, Bistoletti R. Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association. J Hepatol. 2005 Feb;42(2):282-3. PubMed PMID: .

16: Casta?o G, Viudez P, Sookoian S, Carlevaro O, Riccitelli M, Frider B. [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic
and portal hemodynamic events]. Gastroenterol Hepatol. 2000 Jun-Jul;23(6):275-81. Spanish. PubMed PMID: .


17: Macpherson CN, Bartholomot B, Frider B. Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis. Parasitology. 2003;127 Suppl:S21-35. Review.
PubMed PMID: .


18: Sookoian S, Casta?o G, Frider B, Flichman D. How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels. Medicina (B Aires). 2002;62(3):226-30. PubMed PMID:
.

19: Casta?o G, Viudez P, Frider B, Sookoian S. Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis. Gastroenterology. 2002 May;122(5):1544-5. Erratum in:
Gastroenterology 2002 Jul;123(1):397. Gastroenterology 2002 Jul;123(1):396. Gustavo, Castano [corrected to Castano, Gustavo]; Pedro, Viudez [corrected to Viudez, Pedro]; Bernardo, Frider [corrected to Frider, Bernardo]; Silvia, Sookoian [corrected to Sookoian, Silvia]. PubMed PMID: .


20: Neglia V, Sookoian S, Herrera M, Abelda?o A, Kien MC, Chouela E, Frider B.Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b. J Cutan Med Surg. 2001 Sep-Oct;5(5):406-8. PubMed PMID: .


21: Odzak A, Geliberti F, Farace G, Ben?tez S, Bistoletti R, Kozima S, Frider B. [Pancreatic tumor: an unusual presentation of an occult breast carcinoma]. Acta
Gastroenterol Latinoam. 2001;31(5):395-8. Spanish. PubMed PMID: .

22: Larrieu EJ, Frider B. Human cystic echinococcosis: contributions to the natural history of the disease. Ann Trop Med Parasitol. 2001 Oct;95(7):679-87. PubMed PMID: .

23: Frider B, Moguilensky J, Salvitti JC, Odriozola M, Cantoni G, Larrieu E. Epidemiological surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs. Acta Trop. 2001 Jun 22;79(3):219-23. PubMed PMID: .

24: Sookoian S, Casta?o G, Frider B, Cello J, Campos R, Flichman D. Combined therapy with interferon and ribavirin in chronic hepatitis C does not affect serum quasispecies diversity. Dig Dis Sci. 2001 May;46(5):1067-71. PubMed PMID:
.

25: Del Carpio M, Moguilansky S, Costa M, Panomarenko H, Bianchi G, Bendersky S, Lazcano M, Frider B, Larrieu E. Diagnosis of human hydatidosis. Predictive value of a rural ultrasonographic survey in an apparently healthy population. Medicina (B Aires). 2000;60(4):466-8. PubMed PMID: .

26: Sookoian S, Flichman D, Casta?o G, Frider B, Campos R. Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease. Medicina (B Aires). 2000;60(5 Pt 1):587-90. PubMed PMID: .


27: Larrieu E, Frider B, del Carpio M, Salvitti JC, Mercapide C, Pereyra R, Costa M, Odriozola M, P?rez A, Cantoni G, Sustercic J. [Asymptomatic carriers of hydatidosis: epidemiology, diagnosis, and treatment]. Rev Panam Salud Publica. 2000 Oct;8(4):250-6. Spanish. PubMed PMID: .

28: Frider B. [Epidemiology of hepatitis C]. Acta Gastroenterol Latinoam. 2000;30(2):142-4. Spanish. PubMed PMID: .

29: Viudez P, Casta?o G, Sookoian S, Frider B, Alvarez E. Arsenic and portal hypertension. Am J Gastroenterol. 2000 Jun;95(6):1602-4. PubMed PMID: .

30: Schlauder GG, Frider B, Sookoian S, Casta?o GC, Mushahwar IK. Identification of 2 novel isolates of hepatitis E virus in Argentina. J Infect Dis. 2000
Jul;182(1):294-7. Epub 2000 Jul 6. PubMed PMID: .


31: Sookoian S, Neglia V, Casta?o G, Frider B, Kien MC, Chohuela E. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus. Arch Dermatol. 1999 Aug;135(8):1000-1. PubMed PMID: .


32: Casta?o G, Viudez P, Carlevaro O, Ocampo C, Zandalazini H, Riccitelli M, Sookoian S, Frider B. [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis]. Acta Gastroenterol Latinoam. 1998;28(4):291-7. Spanish. PubMed PMID: .

33: Frider B, Larrieu E, Odriozola M. Long-term outcome of asymptomatic liver hydatidosis. J Hepatol. 1999 Feb;30(2):228-31. PubMed PMID: .


34: Quarleri JF, Robertson BH, Mathet V, Sinha SD, Bad?a I, Frider B, Ferro A,Galoppo C, Sookoian S, Casta?o G, Oubi? JR. Genomic and phylogenetic analysis of hepatitis C virus strains from Argentina. Medicina (B Aires). 1998;58(2):153-9. PubMed PMID: 9706248.


35: Frider B, Sookoian S, Casta?o G, Gonz?lez J, Flichman D, Viudez P, Dawson GJ, Schlauder GG, Mushahwar IK. Detection of hepatitis G virus RNA in patients with acute non-A-E hepatitis. J Viral Hepat. 1998 May;5(3):161-4. PubMed PMID: 9658368.

36: Sookoian S, Casta?o G, Castiglioni T, Pilar S, Viudez P, Gonz?lez J, Frider B. [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation]. Medicina (B Aires). 1997;57(6):699-707. Spanish. PubMed PMID: 9674191.


37: Chouela E, Abelda?o A, Panetta J, Ducard M, Neglia V, Sookoian S, Kina M, Casta?o G, Vereytou F, Frider B. Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis. Int J Dermatol. 1996 Nov;35(11):797-9. PubMed PMID: 8915733.


38: Frider B. Hepatic hydatidosis. Acta Gastroenterol Latinoam. 1996;26(3):199-200. PubMed PMID: 9180958.

39: Frider B, Sookoian S, Casta?o G, Giavino G, Chouela E. Lichen planus, chronic hepatitis C and interferon. Hepatology. 1995 Jun;21(6):1764-5. PubMed PMID: 7768527.

40: Frider B, Sookoian S, Casta?o G. [Porphyria cutanea tarda and kidney transplantation]. Medicina (B Aires). 1994;54(3):285-6. Spanish. PubMed PMID:7854102.

41: Frider B, Sookoian S, Casta?o G, R?bora N, Gutfraind Z, Mirta K, Veyretou F, Wainstein C. Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays. Acta Gastroenterol Latinoam. 1994;24(2):71-5. PubMed PMID: 7817696.


42: Frider B, Casta?o G, Sookoian S, Livellara B, Kina M, Sabatiello R,
Castiglione T, Iotti R, V?zquez MC. HBV and HCV infection in kidney transplant recipients. Acta Gastroenterol Latinoam. 1993;23(2):75-81. PubMed PMID: 8249531.


43: Frider B, Rebora N, Bistoletti R, Ocampo C, Sookoian S, Or?a A. [The diagnostic efficacy of ultrasonography-guided puncture cytology in hepatic masses]. G E N. 1992 Jul-Sep;46(3):218-22. Spanish. PubMed PMID: 1340828.


44: Frider B, Sookoian S, Rebora N, Casta?o G, Rozenblat E. [Professional risk: hepatitis B. Vaccination strategies in a general hospital]. Acta Gastroenterol Latinoam. 1992;22(1):29-35. Spanish. PubMed PMID: 1295285.


45: Frider B, Ledesma C, Odriozzola M, Larrieu E. [Echographic specificity in the early diagnosis of human hydatidosis]. Acta Gastroenterol Latinoam. 1990;20(1):13-5. Spanish. PubMed PMID: 2239095.


46: Choc de Zanalda B, Manterola AC, D?az Lestrem M, Frider B, Zocchi GA, Fainboim H, Clua GI, Amor E. [Prevalence of antibody against the hepatitis B core antigen (anti-HBc)among hospital personnel in Buenos Aires]. Bol Oficina Sanit
Panam. 1990 Jan;108(1):16-26. Spanish. PubMed PMID: 2139566.


47: Or?a A, Alvarez J, Chiapetta L, Fontana JJ, Iovaldi M, Paladino A, Bianchi R,
Frider B. Risk factors for acute pancreatitis in patients with migrating
gallstones. Arch Surg. 1989 Nov;124(11):1295-6. PubMed PMID: 2818183.


48: Frider B, Marin AM, Goldberg A. Ultrasonographic diagnosis of portal vein
cavernous transformation in children. J Ultrasound Med. 1989 Aug;8(8):445-9.
PubMed PMID: 2668556.


49: Larrieu E, Frider B, Andreani G, Andreani G, Aquino A, De La Fuente R. [Human
hydatidosis: field echography for the determination of groups at high risk in the
evaluation of a control program]. Rev Inst Med Trop Sao Paulo. 1989
Jul-Aug;31(4):267-70. Spanish. PubMed PMID: 2697070.


50: Frider B, Losada CA, Larrieu E, de Zavaleta O. Asymptomatic abdominal
hydatidosis detected by ultrasonography. Acta Radiol. 1988 Jul-Aug;29(4):431-4.
PubMed PMID: 3044410.

51: Or?a A, Frider B, Alvarez J, Chiappetta L, Souto N, Fontana JJ. Biliary and
pancreatic obstruction during gallstone migration. Int J Pancreatol. 1988
Mar;3(2-3):157-64. PubMed PMID: 3283265.


52: Frider B, Larrieu E, Vargas F, Odriozzola M, Lester R. [An echographic,
serologic and radiologic register of human hydatidosis. Contributions to a
control program]. Acta Gastroenterol Latinoam. 1985;15(4):199-211. Spanish.
PubMed PMID: 3916139.


53: Frider B, Corti OL. [Echography of non-lithiasic pathology of the
gallbladder. Personal experience]. Acta Gastroenterol Latinoam.
1984;14(3):197-212. Spanish. PubMed PMID: 6399427.

Publications

  1. ncbi Autoimmune cholangitis associated to IgG4 related sclerosing disease
    Bernardo Frider
    Departamento de Medicina Hepatología, Hospital General de Agudos C Argerich, Ciudad Autonoma de Buenos Aires, Universidad de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 41:55-9. 2011
  2. ncbi Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association
    Bernardo Frider
    Division of Internal Medicine Hepatology, Hospital General de Agudos Dr Cosme Argerich, Ciudad Autonoma de Buenos Aires, Alte Brown 240, 1155, Buenos Aires, Argentina
    J Hepatol 42:282-3. 2005
  3. ncbi [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events]
    G Castano
    División Clínica Médica, Unidad de Hepatologia, Hospitasl General de Agudos Dr Cosme Argerich, Universidad de Buenos Aires, Argentina
    Gastroenterol Hepatol 23:275-81. 2000
  4. ncbi Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis
    C N L Macpherson
    Windward Islands Research and Education Foundation at St George's University, Grenada, West Indies
    Parasitology 127:S21-35. 2003
  5. ncbi How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels
    Silvia Sookoian
    Unidad de Hepatologia, Departamento de Medicina Interna, Hospital Dr Cosme Argerich, Buenos Aires, Argentina
    Medicina (B Aires) 62:226-30. 2002
  6. ncbi Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
    Gustavo Castano
    Gastroenterology 122:1544-5. 2002
  7. ncbi Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b
    V Neglia
    Dermatology Department, Argerich County Hospital, University of Buenos Aires, Colon 660, Burzaco, Buenos Aires 1852, Argentina
    J Cutan Med Surg 5:406-8. 2001
  8. ncbi [Pancreatic tumor: an unusual presentation of an occult breast carcinoma]
    A Odzak
    , Hospital General de Agudos Dr. Cosme Argerich,
    Acta Gastroenterol Latinoam 31:395-8. 2001
  9. ncbi Human cystic echinococcosis: contributions to the natural history of the disease
    E J Larrieu
    Provincial Council of Public Health, Province of Río Negro, Laprida 240, 8500 Viedma, Argentina
    Ann Trop Med Parasitol 95:679-87. 2001
  10. ncbi Epidemiological surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs
    B Frider
    Division of Internal Medicine Hepatology, Argerich Hospital, Government of Buenos Aires City, Associated to the University of Buenos Aires, Alte Brown 240, 1171, Buenos Aires, Argentina
    Acta Trop 79:219-23. 2001

Collaborators

Detail Information

Publications53

  1. ncbi Autoimmune cholangitis associated to IgG4 related sclerosing disease
    Bernardo Frider
    Departamento de Medicina Hepatología, Hospital General de Agudos C Argerich, Ciudad Autonoma de Buenos Aires, Universidad de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 41:55-9. 2011
    ..The final diagnosis of our patient was autoimmune hepatitis with cholangitis associated to IgG4 systemic diseases...
  2. ncbi Kasabach-Merrit syndrome and adult hepatic epithelioid hemangioendothelioma an unusual association
    Bernardo Frider
    Division of Internal Medicine Hepatology, Hospital General de Agudos Dr Cosme Argerich, Ciudad Autonoma de Buenos Aires, Alte Brown 240, 1155, Buenos Aires, Argentina
    J Hepatol 42:282-3. 2005
    ..A giant hemangioma in adults as well as an hemangioendothelioma in children could be associated KMS, but an HEHE has been rarely reported in association with this syndrome in adult patients...
  3. ncbi [Propranolol and 5-isosorbide mononitrate in patients with cirrhosis: systemic and portal hemodynamic events]
    G Castano
    División Clínica Médica, Unidad de Hepatologia, Hospitasl General de Agudos Dr Cosme Argerich, Universidad de Buenos Aires, Argentina
    Gastroenterol Hepatol 23:275-81. 2000
    ..To study the acute variations in portal and systemic hemodynamics after propranolol and 5-isosorbide mononitrate (IMN) administration in cirrhotic patients...
  4. ncbi Application of ultrasound in diagnosis, treatment, epidemiology, public health and control of Echinococcus granulosus and E. multilocularis
    C N L Macpherson
    Windward Islands Research and Education Foundation at St George's University, Grenada, West Indies
    Parasitology 127:S21-35. 2003
    ....
  5. ncbi How to distinguish normal liver from chronic hepatitis in anti-HCV positive individuals with normal alanine aminotransferase levels
    Silvia Sookoian
    Unidad de Hepatologia, Departamento de Medicina Interna, Hospital Dr Cosme Argerich, Buenos Aires, Argentina
    Medicina (B Aires) 62:226-30. 2002
    ....
  6. ncbi Discussion on randomized comparison of long-term losartan versus propranolol in lowering portal pressure in cirrhosis
    Gustavo Castano
    Gastroenterology 122:1544-5. 2002
  7. ncbi Development of cutaneous sarcoidosis in a patient with chronic hepatitis C treated with interferon alpha 2b
    V Neglia
    Dermatology Department, Argerich County Hospital, University of Buenos Aires, Colon 660, Burzaco, Buenos Aires 1852, Argentina
    J Cutan Med Surg 5:406-8. 2001
    ..A probable induction of sarcoidosis by interferons (IFN) has been published. To this date, few cases of cutaneous sarcoidosis inpatients with chronic hepatitis C under interferon treatment have been reported...
  8. ncbi [Pancreatic tumor: an unusual presentation of an occult breast carcinoma]
    A Odzak
    , Hospital General de Agudos Dr. Cosme Argerich,
    Acta Gastroenterol Latinoam 31:395-8. 2001
    ..Metastases of epithelial origin are uncommon in pancreas and generally are first misdiagnosed as primary pancreatic cancer. Fine needle aspiration is a useful tool for the differential diagnosis in patients with widespread disease...
  9. ncbi Human cystic echinococcosis: contributions to the natural history of the disease
    E J Larrieu
    Provincial Council of Public Health, Province of Río Negro, Laprida 240, 8500 Viedma, Argentina
    Ann Trop Med Parasitol 95:679-87. 2001
    ....
  10. ncbi Epidemiological surveillance of human hydatidosis by means of ultrasonography: its contribution to the evaluation of control programs
    B Frider
    Division of Internal Medicine Hepatology, Argerich Hospital, Government of Buenos Aires City, Associated to the University of Buenos Aires, Alte Brown 240, 1171, Buenos Aires, Argentina
    Acta Trop 79:219-23. 2001
    ..US as a mass screening method allows evaluation of early changes in human prevalence rates, closely related to infestation rates in sheeps and dogs, thus providing a sensitive indicator of the evaluation of control programs...
  11. ncbi Combined therapy with interferon and ribavirin in chronic hepatitis C does not affect serum quasispecies diversity
    S Sookoian
    Internal Medicine Department, Argerich County Hospital, Univesity of Buenos Aires, Argentina
    Dig Dis Sci 46:1067-71. 2001
    ..In conclusion, the complexity of HCV quasispecies before the therapy was not related to treatment response; combined therapy did not affect serum HCV quasispecies...
  12. ncbi Diagnosis of human hydatidosis. Predictive value of a rural ultrasonographic survey in an apparently healthy population
    M del Carpio
    Departamento Zoonosis, Consejo Provincial de Salud Pública de Río Negro, Laprida 240, 8500 Viedma, Argentina
    Medicina (B Aires) 60:466-8. 2000
    ..On the basis of our results, a sensitivity of 100%, a specificity of 95.6% and a global test value of 96.7% were estimated...
  13. ncbi Nonparasitic simple liver cyst: always a benign entity? Unusual presentation of a cystadenoma
    Bernardo Frider
    Department of Internal Medicine, Cosme Argerich Hospital, Buenos Aires, Argentina
    Dig Dis Sci 50:317-9. 2005
  14. ncbi [Development of porphyria cutanea tarda in a chronic hepatitis C patient with indetectable viremia under treatment with peg-interferon plus ribavirin]
    Bernardo Frider
    División Clínica Médica Hepatología Hospital General de Agudos Dr Cosme Argerich, Asociado a la Universidad de Buenos Aires, Alte Brown 240 1155, Ciudad Autonoma de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 36:38-41. 2006
    ..This is another example of the complexity of this association...
  15. ncbi Treatment of liver hydatidosis: how to treat an asymptomatic carrier?
    Bernardo Frider
    World J Gastroenterol 16:4123-9. 2010
    ..At present, it is possible to manage these patients over time and to wait for the best moment for treatment. Follow-up studies must be conducted to achieve this objective...
  16. ncbi Naturally occurring hepatitis B virus (HBV) variants with primary resistance to antiviral therapy and S-mutants with potential primary resistance to adefovir in Argentina
    María L Cuestas
    Centro para el Estudio de Hepatitis Virales, Depto de Microbiologia, Universidad de Buenos Aires, Argentina
    Antiviral Res 87:74-7. 2010
    ..Moreover, the circulation and transmission of S-mutants with resistance to such antiviral drugs should be of public health concern as they may represent an additional risk for the community...
  17. ncbi [Treatment of hepatitis C in patients with extrahepatic diseases]
    Fernando Bessone
    División gastroenterología, Hospital Provincial del Centenario, Rosario, Santa Fe
    Acta Gastroenterol Latinoam 35:S53-5. 2005
  18. ncbi [Renal failure, hemodialysis and renal transplant]
    Bernardo Frider
    División de Clínica Médica Hepatología, Hospital Argerich, Ciudad Autonoma de Buenos Aires
    Acta Gastroenterol Latinoam 35:S13-4. 2005
  19. ncbi [Twenty-four weeks therapy with peginterferon alfa-2a could be similar to 48 weeks therapy in patients with HBeAg positive chronic hepatitis B and good predictors of response: results of a pilot study]
    Joaquín Solari
    Seccion de Hepatologia, Servicio de Clinica Medica, Departamento de Medicina, Hospital Italiano de Buenos Aires CABA, Argentina
    Acta Gastroenterol Latinoam 39:254-60. 2009
    ..Treatment might be shortened particularly in patients with good predictors of response...
  20. ncbi [Statement of the Argentinian Concensus on Hepatitis C 2007]
    Eduardo Fassio
    Hospital Nacional Prof Alejandro Posadas, El Palomar, Provincia de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 38:56-74. 2008
  21. ncbi [Obstructive jaundice associated Burkitt's lymphoma mimicking pancreatic carcinoma]
    Andrea Paissan
    División Clínica Médica Hepatología, Hospital General de Agudos Dr Cosine Argerich, Ciudad Autonoma de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 37:246-9. 2007
    ....
  22. ncbi Successful interferon treatment in a patient chronically infected with hepatitis B virus carrying unusual S- (and P-) mutants in the presence of anti-HBs antibodies
    Bernardo Frider
    Departamento de Medicina Hepatología, Hospital Argerich, Asociado a la Universidad de Buenos Aires UBA, Buenos Aires, Argentina
    Liver Int 27:727-30. 2007
    ....
  23. ncbi [Treatment of viral hepatitis in HIV-HBV-HCV co-infected patients]
    Estela Manero
    , , , Universidad de Buenos Aires
    Acta Gastroenterol Latinoam 36:S59-60; discussion S74-82. 2006
  24. ncbi [Primer treatment of acute and chronic hepatitis C]
    Jorge Daruich
    , , , Universidad de Buenos Aires
    Acta Gastroenterol Latinoam 36:S52-6; discussion S74-82. 2006
  25. ncbi Unusual naturally occurring humoral and cellular mutated epitopes of hepatitis B virus in a chronically infected argentine patient with anti-HBs antibodies
    María L Cuestas
    Departamento Microbiologia, Facultad de Medicina, UBA, Buenos Aires, Argentina
    J Clin Microbiol 44:2191-8. 2006
    ..Moreover, some of the recorded HBsAg variants may influence the accuracy of the results obtained with currently used diagnostic tests...
  26. ncbi Relationship between diversity of hepatitis C quasispecies and histological severity of liver disease
    S Sookoian
    Unidad de Higado, Hospital Argerich, Facultad de Farmacia y Bioquimica, Universidad de Buenos Aires, Argentina
    Medicina (B Aires) 60:587-90. 2000
    ..In conclusion the quasispecies diversity of E2 had no correlation with grade and stage of chronic HCV infection and the presence of quasispecies was independent of the duration of the disease...
  27. ncbi [Asymptomatic carriers of hydatidosis: epidemiology, diagnosis, and treatment]
    E Larrieu
    Consejo Provincial de Salud Pública, Provincia de Río Negro, Argentina
    Rev Panam Salud Publica 8:250-6. 2000
    ....
  28. ncbi [Epidemiology of hepatitis C]
    B Frider
    Acta Gastroenterol Latinoam 30:142-4. 2000
  29. ncbi Lichen planus, chronic hepatitis C and interferon
    B Frider
    Hepatology 21:1764-5. 1995
  30. ncbi [Echography of non-lithiasic pathology of the gallbladder. Personal experience]
    B Frider
    Acta Gastroenterol Latinoam 14:197-212. 1984
    ..85 cases of non lithiasis pathology of the gallbladder is presented. They were found in a revision of 2831 hepatobiliary echographic studies. A correlation with surgery and other methods with the ultrasonographic finding is made...
  31. ncbi [An echographic, serologic and radiologic register of human hydatidosis. Contributions to a control program]
    B Frider
    Acta Gastroenterol Latinoam 15:199-211. 1985
    ..U.S. must be incorporated as an elective method associated with chest X-ray and dd5 in epidemiological yielding and monitoring of control programs for hydatidosis...
  32. ncbi Biliary and pancreatic obstruction during gallstone migration
    A Oria
    Department of Surgery, Hospital General de Agudos Cosme Argerich, Buenos Aires, Argentina
    Int J Pancreatol 3:157-64. 1988
    ..Gallstone migration, even of small stones, was preceded by a period of biliary obstruction. Pain and jaundice before migration were not as frequent as expected...
  33. ncbi Asymptomatic abdominal hydatidosis detected by ultrasonography
    B Frider
    Unit A of Clinical Medicine, Hospital General de Agudos C Argerich, Buenos Aires, Neuquen, Argentina
    Acta Radiol 29:431-4. 1988
    ..Surgery was performed in 32 patients, confirming in all of them the sonographic diagnosis. It is suggested that US should be used in the screening for hydatidosis in high-risk populations as well as in follow-up programmes...
  34. ncbi Risk factors for acute pancreatitis in patients with migrating gallstones
    A Oria
    Department of Surgery, Hospital General de Agudos Cosme Argerich, Buenos Aires, Argentina
    Arch Surg 124:1295-6. 1989
    ....
  35. ncbi [Human hydatidosis: field echography for the determination of groups at high risk in the evaluation of a control program]
    E Larrieu
    Rev Inst Med Trop Sao Paulo 31:267-70. 1989
    ..In conclusion, echography might be incorporated to the epidemiologic surveillance system of human Hydatidosis...
  36. ncbi Ultrasonographic diagnosis of portal vein cavernous transformation in children
    B Frider
    Department of Internal Medicine, Argerich Hospital, Buenos Aires, Argentina
    J Ultrasound Med 8:445-9. 1989
    ..Angiography should be reserved for preoperative or controlled hemodynamic studies...
  37. ncbi [Echographic specificity in the early diagnosis of human hydatidosis]
    B Frider
    Clinica Medica, Hospital Argerich, Buenos Aires
    Acta Gastroenterol Latinoam 20:13-5. 1990
    ..A total of 76 positive subjects were identified with possible hydatid disease. Surgery was performed in 30 patients, conforming in 28 of them sonographic diagnosis (93.34%)...
  38. ncbi [Prevalence of antibody against the hepatitis B core antigen (anti-HBc)among hospital personnel in Buenos Aires]
    B Choc de Zanalda
    Municipalidad de la Ciudad de Buenos Aires, Departamento de Promoción y Protección de la Salud, Argentina
    Bol Oficina Sanit Panam 108:16-26. 1990
    ..The high prevalence of anti-HBc in laboratory technicians, nurses, and nurses' aides might justify their systematic vaccination...
  39. ncbi [The diagnostic efficacy of ultrasonography-guided puncture cytology in hepatic masses]
    B Frider
    Unidad A Clínica Médica Hepatología, Hospital General de Agudos C Argerich, Asociado a la Universidad de Buenos Aires, Argentina
    G E N 46:218-22. 1992
    ..The low sensitivity in hepatocarcinomas is attributable to tumor size and histological differentiation...
  40. ncbi Prevalence of hepatitis C in health care workers investigated by 2nd generation enzyme-linked and line immunoassays
    B Frider
    Internal Medicine Division, Argerich County Hospital, University of Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 24:71-5. 1994
    ..In low risk groups for HCV infection a positive ELISA result with a ratio lower than 3 should be confirmed by more specific tests...
  41. ncbi [Porphyria cutanea tarda and kidney transplantation]
    B Frider
    Medicina (B Aires) 54:285-6. 1994
  42. ncbi Arsenic and portal hypertension
    P Viudez
    Am J Gastroenterol 95:1602-4. 2000
  43. ncbi Identification of 2 novel isolates of hepatitis E virus in Argentina
    G G Schlauder
    Virus Discovery Group, Abbott Laboratories, North Chicago, IL 60064 6269
    J Infect Dis 182:294-7. 2000
    ..Phylogenetic analysis indicate that the Argentine isolates represent a new genotype of HEV, genotype 8, distinct from the Burmese-like genotype 1, Mexican genotype 2, US genotype 3, Chinese/Taiwan genotype 4, and European genotypes 5-7...
  44. ncbi High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic hepatitis C virus
    S Sookoian
    Arch Dermatol 135:1000-1. 1999
  45. ncbi [Evaluation of propranolol response by catheterization and Doppler ultrasonography in patients with cirrhosis]
    G Castano
    División Clínica Médica, Hospital Genral de Agudos Dr Cosme Argerich, Universidad de Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 28:291-7. 1998
    ....
  46. ncbi Long-term outcome of asymptomatic liver hydatidosis
    B Frider
    Division of Internal Medicine, Hepatology Unit, Argerich County Hospital, Associated to the University of Buenos Aires, Argentina
    J Hepatol 30:228-31. 1999
    ..The aim of this study was to determine the outcome of asymptomatic liver hydatid cysts in a cohort of 33 out of 59 carriers by evaluating clinical and ultrasonographic (US) changes 10-12 years after initial diagnosis...
  47. ncbi Genomic and phylogenetic analysis of hepatitis C virus strains from Argentina
    J F Quarleri
    Departmento de Microbiologia, Parasitologia e Inmunologia, Facultad de Medicina, Universidad de Buenos Aires, Argentina
    Medicina (B Aires) 58:153-9. 1998
    ..Besides their epidemiological significance, these results should be taken into account when future vaccines are considered on the basis of geographical HCV genotypic prevalence...
  48. ncbi [The problem of hepatitis C virus infection in blood donors. Clinico-epidemiological, virological and histological evaluation]
    S Sookoian
    División Clínica Médica Hepatología, Hospital Municipal General de Agudos Cosme Argerich, Buenos Aires, Argentina
    Medicina (B Aires) 57:699-707. 1997
    ..Most blood donors with anti HCV(+) had chronic hepatitis C regardless of their serum ALT levels. Normal ALT did not exclude liver disease...
  49. ncbi Detection of hepatitis G virus RNA in patients with acute non-A-E hepatitis
    B Frider
    Division of Internal Medicine, C Argerich County Hospital, Buenos Aires, Argentina
    J Viral Hepat 5:161-4. 1998
    ..The absence of parenteral exposure in most of the HGV RNA-positive patients in this study shows that routes of community-acquired HGV infection are not yet completely understood...
  50. ncbi Hepatic hydatidosis
    B Frider
    Acta Gastroenterol Latinoam 26:199-200. 1996
  51. ncbi Hepatitis C virus antibody (anti-HCV): prevalence in psoriasis
    E Chouela
    Dermatology Unit, Cosme Argerich County Hospital, University of Buenos Aires, Argentina
    Int J Dermatol 35:797-9. 1996
    ..To investigate antibodies to hepatitis C virus (anti-HCV), their prevalence and clinical significance, 118 unselected outpatients with PS were studied prospectively...
  52. ncbi HBV and HCV infection in kidney transplant recipients
    B Frider
    Hepatology Service, Argerich County Hospital, Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 23:75-81. 1993
    ..Seven CPH, 3 MHL. one normal and both cirrhosis cases proved anti-HCV+. HBsAg was positive in the single CAH, in 2 CPH and in one MHL.(ABSTRACT TRUNCATED AT 250 WORDS)..
  53. ncbi [Professional risk: hepatitis B. Vaccination strategies in a general hospital]
    B Frider
    Hospital General de Agudos C Argerich, Unidad Clinica Médica A, Hepatologia, Buenos Aires, Argentina
    Acta Gastroenterol Latinoam 22:29-35. 1992
    ..After the meeting, which were attended by 221 members, 48 individuals, comprising 25 physicians and 23 nurses, spontaneously requested to be vaccinated.(ABSTRACT TRUNCATED AT 250 WORDS)..